CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
74.70
0.34%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Thu: 08:00 - 16:20

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.75
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.015668 %
Charges from full value of position ($-2.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.015668%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.006555 %
Charges from full value of position ($-1.25)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.006555%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 5%
Stock exchange Switzerland
Commission on trade 0%

*Information provided by Capital.com

Galenica AG ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 74.45
Open* 74.4
1-Year Change* -0.33%
Day's Range* 74.1 - 74.9
52 wk Range 65.10-82.20
Average Volume (10 days) 75.76K
Average Volume (3 months) 1.37M
Market Cap 3.72B
P/E Ratio 23.75
Shares Outstanding 49.82M
Revenue 3.91B
EPS 3.13
Dividend (Yield %) 2.95699
Beta 0.42
Next Earnings Date Mar 12, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 27, 2024 74.45 0.35 0.47% 74.10 74.80 73.25
Mar 26, 2024 72.95 -0.60 -0.82% 73.55 74.35 72.95
Mar 25, 2024 73.45 0.60 0.82% 72.85 74.05 71.55
Mar 22, 2024 71.80 -1.50 -2.05% 73.30 73.50 71.80
Mar 21, 2024 72.75 -0.20 -0.27% 72.95 73.60 71.50
Mar 20, 2024 73.40 -0.85 -1.14% 74.25 74.70 73.30
Mar 19, 2024 73.50 -0.90 -1.21% 74.40 74.90 73.25
Mar 18, 2024 75.00 0.95 1.28% 74.05 75.15 73.10
Mar 15, 2024 74.50 1.15 1.57% 73.35 74.65 72.80
Mar 14, 2024 71.95 -0.45 -0.62% 72.40 73.40 71.95
Mar 13, 2024 71.80 -1.25 -1.71% 73.05 73.40 71.60
Mar 12, 2024 72.25 -0.20 -0.28% 72.45 74.40 70.65
Mar 11, 2024 73.35 -1.45 -1.94% 74.80 75.25 73.35
Mar 8, 2024 73.95 -0.95 -1.27% 74.90 75.55 73.75
Mar 7, 2024 74.10 0.60 0.82% 73.50 75.10 73.45
Mar 6, 2024 72.85 -2.00 -2.67% 74.85 75.10 72.85
Mar 5, 2024 74.95 -0.15 -0.20% 75.10 75.80 74.85
Mar 4, 2024 75.55 0.50 0.67% 75.05 75.55 74.55
Mar 1, 2024 74.50 -1.25 -1.65% 75.75 75.95 73.30
Feb 29, 2024 75.65 0.15 0.20% 75.50 76.00 74.50

GALENICA N Events

Time (UTC) Country Event
Wednesday, April 10, 2024

Time (UTC)

10:59

Country

CH

Event

Galenica AG Annual Shareholders Meeting
Galenica AG Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 4014.35 3834.68 3479.75 3301 3165.02
Revenue 4014.35 3834.68 3479.75 3301 3165.02
Cost of Revenue, Total 3001.54 2866.86 2594.01 2448.29 2373
Gross Profit 1012.8 967.816 885.744 852.709 792.015
Total Operating Expense 3811.04 3627.27 3266.43 3131.51 3051.99
Selling/General/Admin. Expenses, Total 634.366 625.055 536.785 554.03 604.407
Depreciation / Amortization 100.322 98.408 93.421 90.766 40.991
Interest Expense (Income) - Net Operating -4.202 -6.765 -4.486 -5.656 -6.999
Unusual Expense (Income) -0.907 -9.366 2.522 -0.061 -0.111
Other Operating Expenses, Total 66.414 37.876 28.475 30.739 40.702
Operating Income 203.31 207.408 213.327 169.491 113.025
Interest Income (Expense), Net Non-Operating -4.786 -4.232 -4.645 -5.111 -2.111
Other, Net 1.102 -0.143 -0.089 -0.987 -0.005
Net Income Before Taxes 199.626 203.033 208.593 163.393 110.909
Net Income After Taxes 165.859 168.183 172.718 125.3 147.664
Minority Interest -0.727 -0.503 -0.474 -0.308 -0.118
Net Income Before Extra. Items 165.132 167.68 172.244 124.992 147.546
Net Income 165.132 167.68 172.244 124.992 147.546
Income Available to Common Excl. Extra. Items 165.132 167.68 172.245 124.992 147.546
Income Available to Common Incl. Extra. Items 165.132 167.68 172.245 124.992 147.546
Diluted Net Income 165.132 167.68 172.245 124.992 147.546
Diluted Weighted Average Shares 49.8036 49.6315 49.4849 49.3508 49.1065
Diluted EPS Excluding Extraordinary Items 3.31567 3.3785 3.48076 2.53272 3.00461
Diluted Normalized EPS 3.30054 3.22218 3.52296 2.53178 3.00314
Dividends per Share - Common Stock Primary Issue 2.2 2.1 1.8 1.8 1.7
Research & Development 13.5 15.2 15.7 13.4
Total Adjustments to Net Income 0.001
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 1851.19 2054.47 1754.21 1977.58 1857.1
Revenue 1851.19 2054.47 1754.21 1977.58 1857.1
Cost of Revenue, Total 1339.45 1540.31 1275.62 1483.82 1389.77
Gross Profit 511.741 514.164 478.586 493.755 467.335
Total Operating Expense 1758.67 1954.51 1655.91 1869.17 1758.1
Selling/General/Admin. Expenses, Total 278.773 274.745 257.47 262.47 256.389
Depreciation / Amortization 51.379 51.173 48.83 50.841 47.589
Interest Expense (Income) - Net Operating -2.948 -2.183 -2.019 -3.017 -3.748
Unusual Expense (Income)
Other Operating Expenses, Total 92.016 90.467 76.006 75.056 68.102
Operating Income 92.521 99.962 98.299 108.405 99.003
Interest Income (Expense), Net Non-Operating -2.507 -1.103 -2.25 -1.407 -2.292
Other, Net -0.471 -0.108 -0.129 -0.631 -0.045
Net Income Before Taxes 89.543 98.751 95.92 106.367 96.666
Net Income After Taxes 74.487 82.734 78.998 88.625 79.558
Minority Interest -0.331 -0.514 -0.213 -0.248 -0.255
Net Income Before Extra. Items 74.156 82.22 78.785 88.377 79.303
Net Income 186.999 82.22 82.912 88.377 79.303
Income Available to Common Excl. Extra. Items 74.155 82.22 78.785 88.376 79.304
Income Available to Common Incl. Extra. Items 186.998 82.22 82.912 88.376 79.304
Diluted Net Income 186.998 82.22 82.912 88.376 79.304
Diluted Weighted Average Shares 49.8661 49.9592 49.6479 49.6981 49.565
Diluted EPS Excluding Extraordinary Items 1.48708 1.64574 1.58687 1.77826 1.6
Dividends per Share - Common Stock Primary Issue 0 2.2 0 2.1 0
Diluted Normalized EPS 1.48708 1.64574 1.58687 1.77826 1.6
Total Adjustments to Net Income -0.001 0 -0.001 0.001
Total Extraordinary Items 112.843 4.127
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 976.718 963.496 812.064 822.849 781.536
Cash and Short Term Investments 93.927 164.982 59.781 90.532 104.97
Cash & Equivalents 93.927 164.982 59.781 90.532 104.97
Total Receivables, Net 529.479 461.108 406.36 421.518 371.648
Accounts Receivable - Trade, Net 505.115 461.108 389.269 421.518 371.648
Total Inventory 315.16 295.07 306.682 277.804 276.628
Prepaid Expenses 38.152 42.336 39.241 32.995 28.29
Other Current Assets, Total
Total Assets 2612.82 2565.8 2258.94 2209.58 1860.09
Property/Plant/Equipment, Total - Net 476.18 460.045 478.38 492.492 244.99
Intangibles, Net 185.409 1020.67 124.634 90.781 76.437
Long Term Investments 47.254 49.848 30.617 37.936 41.189
Other Long Term Assets, Total 3.441 71.747 10.852 10.076 24.463
Total Current Liabilities 880.119 664.899 546.78 553.407 442.577
Accounts Payable 323.345 364.043 289.609 291.789 268.972
Accrued Expenses 211.417 176.147 128.588 119.535 97.88
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 268.637 92.769 88.326 92.426 29.674
Other Current Liabilities, Total 76.72 31.94 40.257 49.657 46.051
Total Liabilities 1367.24 1338.27 1211.66 1216.08 930.625
Total Long Term Debt 417.853 579.878 552.306 563.642 380.91
Long Term Debt 234.848 406.544 381.514 380.87 380.91
Deferred Income Tax 48.384 60.071 48.267 37.019 25.579
Minority Interest 3.881 6.14 6.073 6.043 4.136
Other Liabilities, Total 17.008 27.277 58.23 55.971 77.423
Total Equity 1245.58 1227.54 1047.28 993.497 929.463
Common Stock 5 5 5 5 5
Retained Earnings (Accumulated Deficit) 1248.4 1237.05 1062.1 1014.46 956.662
Total Liabilities & Shareholders’ Equity 2612.82 2565.8 2258.94 2209.58 1860.09
Total Common Shares Outstanding 49.8163 49.6385 49.4986 49.3391 49.1766
Property/Plant/Equipment, Total - Gross 852.779 841.033 833.479 567.016
Accumulated Depreciation, Total -376.599 -362.653 -340.987 -322.026
Goodwill, Net 914.703 791.588 755.445 691.473
Treasury Stock - Common -7.817 -14.511 -19.817 -25.964 -32.199
Capital Lease Obligations 183.005 173.334 170.792 182.772
Note Receivable - Long Term 9.12 10.803
Other Equity, Total -0.001
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 941.03 976.718 887.894 963.496 974.271
Cash and Short Term Investments 15.329 93.927 20.966 164.982 124.418
Cash & Equivalents 15.329 93.927 20.966 164.982 124.418
Total Receivables, Net 557.695 529.479 533.369 461.108 523.721
Accounts Receivable - Trade, Net 557.695 529.479 533.369 461.108 523.721
Total Inventory 335.04 315.16 296.32 295.07 284.701
Prepaid Expenses 32.966 38.152 37.239 42.336 41.431
Total Assets 2808.94 2612.82 2454.46 2565.8 2513.6
Property/Plant/Equipment, Total - Net 480.455 476.18 473.547 460.045 488.845
Intangibles, Net 1068.35 1100.11 1034.89 1020.67 953.368
Long Term Investments 314.244 56.374 53.998 49.848 48.717
Other Long Term Assets, Total 4.866 3.441 4.131 71.747 48.397
Total Current Liabilities 741.553 880.119 835.025 664.899 753.54
Accounts Payable 361.16 355.22 335.71 364.043 371.519
Accrued Expenses 190.47 211.417 178.279 176.147 175.971
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 158.725 268.637 293.098 92.769 187.279
Other Current Liabilities, Total 31.198 44.845 27.938 31.94 18.771
Total Liabilities 1483.65 1367.24 1295.04 1338.27 1405.74
Total Long Term Debt 662.699 417.853 391.401 579.878 561.49
Long Term Debt 476.499 234.848 206.292 406.544 381.458
Capital Lease Obligations 186.2 183.005 185.109 173.334 180.032
Deferred Income Tax 57.656 48.384 48.156 60.071 58.447
Minority Interest 3.639 3.881 3.663 6.14 5.996
Other Liabilities, Total 18.106 17.008 16.799 27.277 26.265
Total Equity 1325.29 1245.58 1159.42 1227.54 1107.86
Common Stock 5 5 5 5 5
Retained Earnings (Accumulated Deficit) 1330.46 1248.4 1165.28 1237.05 1102.86
Treasury Stock - Common -10.169 -7.817 -10.862 -14.511
Total Liabilities & Shareholders’ Equity 2808.94 2612.82 2454.46 2565.8 2513.6
Total Common Shares Outstanding 49.8163 49.8163 49.6385 49.6385 49.4986
Other Equity, Total -0.001 -0.001
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 165.859 168.183 172.718 125.3 147.664
Cash From Operating Activities 236.874 333.095 224.36 250.438 173.55
Cash From Operating Activities 100.474 98.43 96.157 90.845 40.991
Non-Cash Items 8.132 0.214 -38.983 5.626 40.141
Cash Taxes Paid -5.649 -16.146 -10.587 -15.997 50.045
Cash Interest Paid 5.612 4.695 4.934 4.889 2.345
Changes in Working Capital -37.591 66.268 -5.532 28.667 -55.246
Cash From Investing Activities -126.552 -88.236 -115.649 -134.894 -87.582
Capital Expenditures -70.366 -60.073 -55.687 -53.588 -47.452
Other Investing Cash Flow Items, Total -56.186 -28.163 -59.962 -81.306 -40.13
Cash From Financing Activities -181.276 -139.634 -139.49 -129.981 -77.283
Financing Cash Flow Items -4.068 -0.109 -0.189 -0.166 -0.175
Total Cash Dividends Paid -104.81 -89.509 -89.216 -83.758 -81.029
Issuance (Retirement) of Debt, Net -76.745 -53.875 -53.863 -48.591 1.295
Foreign Exchange Effects -0.101 -0.024 0.027 -0.001 -0.002
Net Change in Cash -71.055 105.201 -30.752 -14.438 8.683
Issuance (Retirement) of Stock, Net 4.347 3.859 3.778 2.534 2.626
Dec 2022 Jun 2022 Dec 2021 Jun 2021 Dec 2020
Net income/Starting Line 165.859 83.124 168.183 79.559 172.718
Cash From Operating Activities 236.874 39.219 333.095 138.619 224.36
Cash From Operating Activities 100.474 49.301 98.43 47.589 96.157
Non-Cash Items 8.132 1.257 0.214 6.187 -38.983
Cash Taxes Paid -5.649 3.985 -16.146 -4.5 -10.587
Cash Interest Paid 5.612 2.068 4.695 1.852 4.934
Changes in Working Capital -37.591 -94.463 66.268 5.284 -5.532
Cash From Investing Activities -126.552 -47.671 -88.236 -57.883 -115.649
Capital Expenditures -70.366 -29.743 -60.073 -24.04 -55.687
Other Investing Cash Flow Items, Total -56.186 -17.928 -28.163 -33.843 -59.962
Cash From Financing Activities -181.276 -135.464 -139.634 -16.136 -139.49
Financing Cash Flow Items -4.068 -4.414 -0.109 -0.352 -0.189
Total Cash Dividends Paid -104.81 -104.443 -89.509 -89.204 -89.216
Issuance (Retirement) of Stock, Net 4.347 -0.178 3.859 -0.098 3.778
Issuance (Retirement) of Debt, Net -76.745 -26.429 -53.875 73.518 -53.863
Foreign Exchange Effects -0.101 -0.1 -0.024 0.037 0.027
Net Change in Cash -71.055 -144.016 105.201 64.637 -30.752

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Galenica AG Company profile

About Galenica AG

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Galenica AG revenues increased 10% to SF3.83B. Net income applicable to common stockholders decreased 3% to SF167.7M. Revenues reflect Products & Care segment increase of 14% to SF1.83B, Logistics & IT segment increase of 7% to SF2B, Other countries segment increase of 13% to SF30.6M. Net income was offset by Personnel costs increase of 17% to SF518.9M (expense).

Industry: Pharmaceuticals Wholesale

Untermattweg 8
BERN
BERN 3027
CH

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

ETH/USD

3,567.64 Price
+1.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

70,819.35 Price
+2.860% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

US100

18,249.80 Price
-0.090% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

2,217.38 Price
+1.110% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading